1. Home
  2. XLO vs TACT Comparison

XLO vs TACT Comparison

Compare XLO & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.63

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$3.29

Market Cap

37.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
TACT
Founded
2016
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
37.2M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
XLO
TACT
Price
$8.63
$3.29
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$28.00
$5.00
AVG Volume (30 Days)
186.9K
55.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.88
EPS
N/A
N/A
Revenue
$43,766,000.00
N/A
Revenue This Year
$88.66
$10.36
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$3.06
52 Week High
$9.25
$5.70

Technical Indicators

Market Signals
Indicator
XLO
TACT
Relative Strength Index (RSI) 86.23 53.35
Support Level $0.63 N/A
Resistance Level $9.25 $3.85
Average True Range (ATR) 0.60 0.21
MACD 0.07 0.02
Stochastic Oscillator 70.82 62.90

Price Performance

Historical Comparison
XLO
TACT

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: